Laurus labs is an innovation-driven¸ people-centric & client-focused organization offering a broad and integrated portfolio of products & services to the global pharmaceutical industry. Equipped with a world-class infrastructure manned by best-in-class personnel & driven by the core values of knowledge, innovation and excellence, within a relatively short period, Laurus labs emerged as a segment-leading manufacturer of high quality APIs, a preferred partner for NCE development & manufacture & a trusted source of specialty ingredients for the nutraceutical industry. Given the strengths, capabilities & experience, Laurus Labs is uniquely positioned to help its clients in their endeavor of ‘quicker to market’ & thus contributing towards improving access to quality & affordable healthcare worldwide.

China State Institute of Pharmaceutical Industry is a Chinese company located in Shanghai and ultimately controlled by the Government of China. The firm regulates pharmaceutical companies.

Jinan Aisi Pharmaceutical Technology Co., Ltd., established on 2010-07-30, Business scope includes pharmaceutical,biological technology development,Technical Services,technical consulting,technology transfer;Chemical API,Development of pharmaceutical intermediates,production and sales;Chemical Products(Free of Hazardous Chemicals),Technical development of instrumentation,Technical Services,technical consulting,Technology Transfer and Sales;medicine,pesticide,Cleaning Products,Pre-packaged food,Healthy food,Non-specially controlled agricultural and sideline products,Biological product(No vaccine)testing and sales;Import and export of goods and technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval)and other legal,regulations,Items that are not prohibited by the State Council's decision and do not require a business license.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. Qilu focuses on the development, manufacturing and marketing of generic drugs and active pharmaceutical ingredients(APIs) in therapeutic areas including but not limited to Oncology, Cerebrovascular & Cardiovascular, Anti-infections, Psychological & Neurological Systems, Respiratory System, and Ophthalmological Diseases. Qilu has more than 15,000 employees, 70% of whom have a college degree or above. Qilu Pharmaceutical consistently focuses on revolutionary development strategies guided by market demand and product innovation. Qilu has established extensive cooperation with domestic and international partners on multiple R&D projects. Devoted to the cultivation of talent, Qilu has invested in a highly qualified R&D team and efficient R&D capabilities. The 200+ new drug products successfully developed by Qilu constitutes as a large part of future production and sales for Qilu Pharmaceutical and partners. A number of technological achievements have garnered national and provincial scientific and technological progress awards for Qilu.

Part of Hansoh Pharmaceutical Group Co., Ltd., Jiangsu Hansoh Pharmaceutical Co. Ltd. is a Chinese company located in Jiangsu. The firm manufactures and distributes pharmaceutical products.

Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.

Asymchem Laboratories (Fuxin) Co. Ltd., a subsidiary of Asymchem Laboratories, Inc., is a Chinese company located in Fuxin. The firm manufactures carbapenem products.

Tianjin Kailaiying Pharmaceutical Co., Ltd., established on 2010-07-19, Business scope includes general items:R&D of industrial enzyme preparations;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Fermentation process optimization technology research and development;Pharmaceutical special equipment manufacturing;Pharmaceutical special equipment sales;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals)Medical Research and Experimental Development;General Cargo Warehousing Services(Does not contain hazardous chemicals and other items requiring permits);Non-residential real estate leases;Special equipment rental(Except for projects subject to approval according to law,Carry out business activities independently in accordance with the law with a business license).licensed items:pharmaceutical production;Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business items are subject to relevant approval documents or licenses)

Tianjin Institute of Pharmaceutical Research Co., Ltd. engages in the in the development of various new products such as innovative drugs, generic drugs, new preparations, traditional Chinese medicines, and biological drugs with particular emphasis on the engineering and industrialization of new technologies to meet drug registration requirements. The company was founded in 1959 and is headquartered in Tianjin, China.

Part of Asymchem Laboratories (Tianjin) Co., Ltd., Asymchem Life Science Tianjin Co. Ltd. is a Chinese company located in Tianjin. The firm manufactures pharmaceutical raw materials. Yi Xiao is the current CEO, occupying that position since 2018.

Formosa Laboratories, Inc. produces APIs and UV-filters in its modern facilities near Taipei. Its GMP compliance has been approved by DOH of Taiwan, US FDA, BGV of Germany, EDQM and PMDA of Japan. Formosa’s major API products include Vitamin D derivatives (Alfacalcidol, Calcitriol, Calcipotriol, Doxercalciferol, and Paricalcitol), Balsalazide, Benzonatate, Capsaicin, Colesevelam, Gadodiamide, Flupentixol, Melitracen, Meprobamate, Montelukast, Mycophenolate Mofetil, Sevelamer (HCl and Carbonate), and Taltirelin. As a major producer in the world, our UV-filter products include avobenzone and Octinoxate. We also provide custom synthesis service from process development to full commercial production for APIs and other specialty chemicals, with full documentation support.

Jilin Asymchem Laboratories Co. Ltd., a subsidiary of Asymchem Laboratories, Inc., is a company headquartered in Dunhua, China. The firm provides research-based contract manufacturing services.

Asymchem Laboratories (Tianjin) Co., Ltd. engages in the research and development, and production of intermediates, and active pharmaceutical ingredients. Its business scopes include small molecule contract development and manufacturing organization (CDMO), and emerging service businesses. Its Small Molecule CDMO business provides process development and analysis, clinical drug production, new drug application and approval services, and current good manufacturing practice commercial production services. Its Emerging Service business covers chemical macromolecules, formulations, biosynthesis technology, biological macromolecules, and clinical research services. The company was founded by Hao Hong on October 7, 1998 and is headquartered in Tianjin, China.

Bonuo Kangyuan (Beijing) Pharmaceutical Technology Co. Ltd. is a Chinese private company with domestic subsidiaries, that manufactures drugs, medical devices and sells chemical products.

Shandong Bomaikang Pharmaceutical Research Co., Ltd., established on 2004-06-22, Business scope includes medical research and experimental development;medicine,pesticide,veterinary medicine,Biopharmaceuticals,Pharmaceutical Intermediates,medical instruments,Chemical raw materials(Does not contain dangerous goods),Technology development of health food and health products,Technical Services,technology transfer,technical consulting;Chemical Products(Free of Hazardous Chemicals),medicine,Pharmaceutical Intermediates,Instrumentation,pesticide,Cleaning Products,Pre-packaged food,Healthy food,Non-specially controlled agricultural and sideline products,Biological product(No vaccine)promotion of;Import and export of goods and technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval)and other legal,regulations,Items that are not prohibited by the State Council's decision and do not require a business license.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shandong Huizhi Pharmaceutical Research Co., Ltd., established on 2020-09-09, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Chemical product sales(No licensed chemical products);Instrument sales;Pharmaceutical special equipment sales;Drug testing equipment sales;Experimental analysis instrument sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Synthetic Materials Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Brose Green (Shandong) Pharmaceutical Co., Ltd., established on 2020-07-27, Business scope includes general items:Engineering and Technology Research and Experimental Development;Chemical product sales(No licensed chemical products);Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:pharmaceutical production;Pharmaceutical commissioned production;Technology Import and Export;Production of Class II Medical Devices;Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Shanxi Zhendong Pharmaceutical Co., Ltd. engages in the research and development, manufacture and distribution of Chinese traditional medicines and western medicines. Its products include Yanshu injection, Norfloxacin, Shuxuening injection, Guanxinning injection, Amoxicillin Sodium for injection, Cefathiamidine for injection and Riboflavin Sodium Phosphate for injection. The company was founded on November 22, 1993 and is headquartered in Changzhi, China.

Lianyungang Hongchuang Pharmaceutical Co., Ltd., established on 2003-01-13, Business scope includes pharmaceutical production(Operate according to the scope approved by the license);Research on new pharmaceutical products;electronic product,Pharmaceutical and chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Mechanical equipment and parts,Instrumentation,metal products,ceramics,Decoration materials(Hazardous chemicals excluded),Hardware and electrical sales;Self-operated and agent import and export business of various commodities and technologies,Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)